Fonte: Fundamental and Clinical Pharmacology. Nome do evento: EPHAR 2008 Congress. Unidade: ICB
Assunto: FISIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WENCESLAU, C. et al. Long-term treatment with ouabain induces endothelial dysfunction that increases the vasoconstriction to noradrenaline of mesenteric resistance arteries. Fundamental and Clinical Pharmacology. Manchester: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 03 nov. 2025. , 2008APA
Wenceslau, C., Couto, G., Davel, A. P., & Rossoni, L. V. (2008). Long-term treatment with ouabain induces endothelial dysfunction that increases the vasoconstriction to noradrenaline of mesenteric resistance arteries. Fundamental and Clinical Pharmacology. Manchester: Instituto de Ciências Biomédicas, Universidade de São Paulo.NLM
Wenceslau C, Couto G, Davel AP, Rossoni LV. Long-term treatment with ouabain induces endothelial dysfunction that increases the vasoconstriction to noradrenaline of mesenteric resistance arteries. Fundamental and Clinical Pharmacology. 2008 ; 22[citado 2025 nov. 03 ]Vancouver
Wenceslau C, Couto G, Davel AP, Rossoni LV. Long-term treatment with ouabain induces endothelial dysfunction that increases the vasoconstriction to noradrenaline of mesenteric resistance arteries. Fundamental and Clinical Pharmacology. 2008 ; 22[citado 2025 nov. 03 ]
